Finance

Lists
ISRG:NASDAQ
Intuitive Surgical Inc
$376.86
+1.14%
(+4.26) 1D
$376.86
0.00% (0.00)
After hours
Closed: Aug 31, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ISRG...
Open
$369.00
High
$377.37
Low
$365.32
Mkt. cap
54.41B
Avg. vol.
3.09M
Volume
1.92M
P/E ratio
43.19
52-wk high
$603.88
52-wk low
$328.57
EPS
$8.73
Beta
1.47
Shares outstanding
353.28M
No. of employees
23K
Open
$369.00
High
$377.37
Low
$365.32
Mkt. cap
54.41B
Avg. vol.
3.09M
Volume
1.92M
P/E ratio
43.19
52-wk high
$603.88
52-wk low
$328.57
EPS
$8.73
Beta
1.47
Shares outstanding
353.28M
No. of employees
23K
News stories
From web sources and news partners
Profile
Coherent Corp. is an American manufacturer of optical materials and semiconductors. As of 2023, the company had 26,622 employees. Its stock is listed on the New York Stock Exchange under the ticker symbol COHR. In 2022, II-VI acquired laser manufacturer Coherent, Inc., and adopted its name. Wikipedia
About Intuitive Surgical Inc
CEOJim Anderson | Zhao Qixiang | Patrizio Vinciarelli | David J. Rosa | Zhu Yiming
Employees23.5K
FoundedJul 28, 2006
HeadquartersAndover, Massachusetts, United States
SectorMedical device
Websitecoherent.com
Analyst ratings
Based on 24 analysts giving stock ratings to ISRG in the past 3 months
Strong buy
Buy
20
Hold
3
Sell
1
12-month forecast
Based on 24 Wall Street analysts offering 12 month price targets for ISRG in the last 3 months.
Highest
Current $376.86
$685.00 (+81.77%)
Average
$487.29 (+29.30%)
Lowest
$366.00 (-2.88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vik Chopra
BMO Capital
Buy
Maintained
-
-
08/28/2026
Adam Maeder
Piper Sandler
Buy
Maintained
$470.00
+24.7%
08/21/2026
Joanne Wuensch
Citi
Buy
Maintained
$500.00
+32.7%
08/13/2026
Lee Hambright
Bernstein
Buy
Maintained
$685.00
+81.8%
08/11/2026
Suraj Kalia
Oppenheimer
Buy
Upgraded
$500.00
+32.7%
08/12/2026
Travis Steed
Bank of America Securities
Buy
Maintained
$470.00
+24.7%
08/11/2026
Mathew Blackman
TD Cowen
Buy
Maintained
$485.00
+28.7%
08/03/2026
Helen Fang
HSBC
Hold
Downgraded
$391.00
+3.8%
07/30/2026
Patrick Wood
UBS
Buy
Upgraded
$500.00
+32.7%
07/28/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
$487.00
+29.2%
07/23/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
$450.00
+19.4%
07/21/2026
Unknown Analyst
Mirae Asset
Buy
Upgraded
-
-
07/21/2026
Jayson Bedford
Raymond James
Buy
Maintained
$483.00
+28.2%
07/17/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
07/17/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
$575.00
+52.6%
07/16/2026
David Rescott
Robert W. Baird
Buy
Maintained
$500.00
+32.7%
07/17/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
$454.00
+20.5%
07/17/2026
Ryan Zimmerman
BTIG
Buy
Maintained
$469.00
+24.4%
07/17/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
$550.00
+45.9%
07/17/2026
Richard Newitter
Truist Financial
Buy
Reiterated
$510.00
+35.3%
07/17/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
$400.00
+6.1%
07/15/2026
Unknown Analyst
BMO Capital
Buy
Initiated
$518.00
+37.5%
07/09/2026
Vijay Kumar
Evercore ISI
Hold
Maintained
$430.00
+14.1%
07/06/2026
David Roman
Goldman Sachs
Buy
Reiterated
$558.00
+48.1%
06/15/2026
Imron Zafar
Deutsche Bank
Sell
Maintained
$366.00
-2.9%
06/02/2026
Unknown Analyst
Erste Group
Hold
Maintained
-
-
05/05/2026
Matt Miksic
Barclays
Buy
Reiterated
$651.00
+72.7%
04/23/2026
Unknown Analyst
Jefferies
Hold
Reiterated
$515.00
+36.7%
04/22/2026
Nico Chen
DBS
Hold
Maintained
$480.00
+27.4%
03/18/2026
Danielle Antalffy
UBS
Hold
Reiterated
$550.00
+45.9%
03/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2026
Mar 2026
Jun 2026
Jun 2026
Revenue
1.81B
112.97M
2.05B
2.89B
Cost of goods sold
1.13B
50.60M
1.26B
60.23M
Cost of revenue
1.13B
50.60M
1.26B
931.90M
Research and development expenses
185.98M
361.90M
216.38M
370.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248.90M
23.19M
328.78M
617.90M
Operating expense
434.88M
975.20M
545.16M
48.24M
Total operating expenses
1.56B
1.41B
1.80B
108.47M
Operating income
245.06M
855.30M
241.92M
971.90M
Other non operating income
28.07M
16.53M
70.62M
251.00K
EBT including unusual items
184.35M
20.40M
278.51M
38.92M
EBT excluding unusual items
228.57M
20.32M
269.48M
1.05B
Income tax expense
2.67M
114.40M
42.31M
231.40M
Effective tax rate
1.45%
-1.34%
15.19%
-27.91%
Other operating expenses
-
-
-
-
Net income
191.40M
226.35M
240.53M
49.77M
Net profit margin
10.60%
29.65%
11.76%
34.72%
Earnings per share
1.41
0.52
1.74
1.29
Interest and investment income
-
3.27M
-
3.35M
Interest expense
-44.56M
-58.72M
-41.05M
-45.94M
Net interest expenses
-44.56M
3.27M
-41.05M
3.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
377.94M
22.22M
382.49M
40.30M
Gain or loss from assets sale
-8.14M
-7.90M
-326.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps